Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Straznicka

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Surgery|March 29, 2001
Preoperative evaluationJ P. Sutyak, M Straznicka, R J. Leone
Basic Research in Cardiology|April 7, 2000
Cyclic GMP attenuates cyclic AMP-stimulated inotropy and oxygen consumption in control and hypertrophic heartsR J Leone, M Straznicka, P M Scholz, et al.
Journal of Cardiovascular Pharmacology|February 15, 2000
Nitroprusside reverses lengthened time of contraction in stunned canine cardiac myocytesM Straznicka, P M Scholz, G Gong, et al.
Journal of Cardiovascular Pharmacology|August 13, 1999
Cyclic GMP protein kinase mediates negative metabolic and functional effects of cyclic GMP in control and hypertrophied rabbit cardiac myocytesM Straznicka, G Gong, L Yan, et al.
The Journal of Surgical Research|August 8, 1998
Myocardial effects of cyclic AMP phosphodiesterase inhibition are dampened in thyroxine-induced cardiac hypertrophyM Straznicka, R J Leone, P M Scholz, et al.
Canadian Journal of Physiology and Pharmacology|October 28, 1999
Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiac myocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterasesH R Weiss, G X Gong, M Straznicka, et al.
Journal of Autonomic Pharmacology|June 29, 1999
Altered effects of acetylcholine on cyclic AMP and GMP induced changes in O2 consumption of hypertrophic dog cardiac myocytesG X Gong, M Straznicka, H R Weiss, et al.
The American Journal of Physiology|November 15, 1997
cGMP level that reduces cardiac myocyte O2 consumption is altered in renal hypertensionM Straznicka, G Gong, J Tse, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Surgery|March 29, 2001
Preoperative evaluationJ P. Sutyak, M Straznicka, R J. Leone
Basic Research in Cardiology|April 7, 2000
Cyclic GMP attenuates cyclic AMP-stimulated inotropy and oxygen consumption in control and hypertrophic heartsR J Leone, M Straznicka, P M Scholz, et al.
Journal of Cardiovascular Pharmacology|February 15, 2000
Nitroprusside reverses lengthened time of contraction in stunned canine cardiac myocytesM Straznicka, P M Scholz, G Gong, et al.
Journal of Cardiovascular Pharmacology|August 13, 1999
Cyclic GMP protein kinase mediates negative metabolic and functional effects of cyclic GMP in control and hypertrophied rabbit cardiac myocytesM Straznicka, G Gong, L Yan, et al.
The Journal of Surgical Research|August 8, 1998
Myocardial effects of cyclic AMP phosphodiesterase inhibition are dampened in thyroxine-induced cardiac hypertrophyM Straznicka, R J Leone, P M Scholz, et al.
Canadian Journal of Physiology and Pharmacology|October 28, 1999
Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiac myocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterasesH R Weiss, G X Gong, M Straznicka, et al.
Journal of Autonomic Pharmacology|June 29, 1999
Altered effects of acetylcholine on cyclic AMP and GMP induced changes in O2 consumption of hypertrophic dog cardiac myocytesG X Gong, M Straznicka, H R Weiss, et al.
The American Journal of Physiology|November 15, 1997
cGMP level that reduces cardiac myocyte O2 consumption is altered in renal hypertensionM Straznicka, G Gong, J Tse, et al.
Pageof 1